Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_3
4
80%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Active, not recruiting2
Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (20.0%)
Phase 34 (80.0%)

Trials by Status

active_not_recruiting240%
completed240%
recruiting120%

Recent Activity

3 active trials
Showing 5 of 5
recruitingphase_3

Study to Assess the Safety and Effectiveness of NMRA-335140-501

NCT06029439
active_not_recruitingphase_3

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

NCT06058013
active_not_recruitingphase_3

Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder

NCT06058039
completedphase_3

Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

NCT06029426
completedphase_2

Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo

NCT04221230

Clinical Trials (5)

Showing 5 of 5 trials
NCT06029439Phase 3

Study to Assess the Safety and Effectiveness of NMRA-335140-501

Recruiting
NCT06058013Phase 3

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Active Not Recruiting
NCT06058039Phase 3

Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder

Active Not Recruiting
NCT06029426Phase 3

Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Completed
NCT04221230Phase 2

Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5